Clinic Nuclear Medicine Pharmaceutical 
AuntMinnie
NOVEMBER 20, 2024
Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclear medicine. Telix said these new therapeutic assets are differentiated by a structure that drives extended tumor retention while minimizing off-target uptake.
AuntMinnie
JUNE 3, 2024
Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JULY 12, 2024
As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclear medicine technologists means a theranostics center may need to limit its patient volume.
AuntMinnie
JANUARY 2, 2025
Telix Pharmaceuticals and the Brussels-based Oncidium foundation are highlighting results from the NOBLE Registry of TLX599-CDx (technetium-99m [Tc-99m] inhibitor of prostate-specific membrane antigen [iPSMA]), published in the European Journal of Nuclear Medicine and Molecular Imaging Reports.
AuntMinnie
JUNE 10, 2024
Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He has also co-founded, consulted, and/or served on the scientific advisory board of several biotech companies, including Oric Pharmaceuticals, Enlaza Therapeutics, and HoneyBear Biosciences.
Imaging Technology
MAY 25, 2023
This inclusion in the NCCN Guidelines comes after the Society of Nuclear Medicine and Molecular Imaging ( SNMMI ) recently published Appropriate Use Criteria to guide referring and imaging physicians in appropriate use of estrogen receptor (ER)-targeted PET imaging with 16α- 18 F-fluoro-17ß Fluoroestradiol. In the U.S.,
AuntMinnie
DECEMBER 1, 2023
In photon-counting CT technology developments, GEHC said that researchers at Stanford Medicine have begun scanning human subjects using its photon-counting CT prototype. GEHC also displayed its Signa PET/MR AIR system, which was introduced at the annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in June.
Expert insights. Personalized for you.
130 
Let's personalize your content